University of Tasmania
Browse

File(s) not publicly available

Baclofen does plasma level monitoring have a clinical role

journal contribution
posted on 2023-05-18, 22:04 authored by Gregory PetersonGregory Peterson, Stuart McLeanStuart McLean, Millingen, KS
Patients vary considerably in their dosage requirements of the muscle relaxant drug, baclofen. A study was therefore performed to determine whether plasma level monitoring of baclofen would assist in the individualization of its dosage. Maintenance dosages, steady-state peak and trough plasma concentrations of baclofen, and clinical response were examined in 13 patients with varying degrees of muscle spasticity. Peak plasma concentrations of baclofen and clinical response were significantly related, but the relationship was weaker than that observed between daily dosage and clinical response. It can be concluded that plasma level monitoring would have only a limited clinical role in ascertaining whether baclofen dosage is adequate.sbd.most patients will require a dosage of at least 50 daily, resulting in steady-state plasma concentrations above 250 ng/mL (peak) and 50 ng/mL (trough).

History

Publication title

Journal of Pharmacy Practice and Research

Volume

21

Pagination

20-24

ISSN

1445-937X

Department/School

College Office - College of Health and Medicine

Publisher

Wiley-Blackwell Publishing Ltd.

Place of publication

United Kingdom

Repository Status

  • Restricted

Socio-economic Objectives

Allied health therapies (excl. mental health services)

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC